Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-06-12 Purchase | 2023-06-14 4:00 pm | Oncternal Therapeutics Inc. | ONCT | Kaufmann Gunnar F. Chief Scientific Officer | 28,000 | $0.35086 | $9,824 | 94,726 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-02-21 Option Award | 2023-02-23 8:00 pm | N/A 2033-02-21 | Oncternal Therapeutics Inc. | ONCT | Kaufmann Gunnar F. Chief Scientific Officer | 210,000 | $0 | 210,000 (Direct) | View |
2023-01-03 Tax Withholding | 2023-01-05 6:00 pm | N/A N/A | Oncternal Therapeutics Inc. | ONCT | Kaufmann Gunnar F. Chief Scientific Officer | 6,266 | $1.02 | 66,726 (Direct) | View |
2022-07-28 Option Award | 2022-08-01 6:21 pm | N/A 2032-07-28 | Oncternal Therapeutics Inc. | ONCT | Kaufmann Gunnar F. Chief Scientific Officer | 71,875 | $0 | 101,742 (Direct) | View |
2022-01-20 Option Award | 2022-01-24 4:00 pm | N/A 2032-01-20 | Oncternal Therapeutics Inc. | ONCT | Kaufmann Gunnar F. Chief Scientific Officer | 162,457 | $0 | 162,457 (Direct) | View |
2022-01-03 Option Award | 2022-01-05 7:00 pm | N/A N/A | Oncternal Therapeutics Inc. | ONCT | Kaufmann Gunnar F. Chief Scientific Officer | 29,867 | $0 | 29,867 (Direct) | View |
2021-02-11 Option Award | 2021-02-16 6:00 pm | N/A 2031-02-11 | Oncternal Therapeutics Inc. | ONCT | Kaufmann Gunnar F. Chief Scientific Officer | 253,000 | $0 | 253,000 (Direct) | View |
2020-03-17 Option Award(A) | 2020-07-31 9:06 pm | N/A 2030-03-17 | Oncternal Therapeutics Inc. | ONCT | Kaufmann Gunnar F. Chief Scientific Officer | 14,260 | $0 | 14,260 (Direct) | View |
2020-03-17 Option Award | 2020-03-18 6:49 pm | N/A 2030-03-17 | Oncternal Therapeutics Inc. | ONCT | Kaufmann Gunnar F. Chief Scientific Officer | 14,260 | $0 | 14,260 (Direct) | View |